| For: | Wu GY, Chen HS. Novel approaches towards conquering hepatitis B virus infection. World J Gastroenterol 2007; 13(6): 830-836 [PMID: 17352010 DOI: 10.3748/wjg.v13.i6.830] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i6/830.htm |
| Number | Citing Articles |
| 1 |
Wei Jia, Yanfang Zhao, Rongdong Li, Yanjiao Wu, Zebiao Li, Ping Gong. Synthesis and In‐Vitro Anti‐Hepatitis‐B Virus Activity of 6H‐[1]Benzothiopyrano[4,3‐b] quinolin‐10‐ols. Archiv der Pharmazie 2009; 342(9) doi: 10.1002/ardp.200900070
|
| 2 |
Zhanpeng Yan, Tingting Xu, Kelei Su, Chi Wang, Tong Yan, Zhong Hua, Erli Gu, Fangshi Zhu, J.Q. Cheng, H.L. Moffitt, I. Kim, Z.T. Chi, J. Zhang. Investigation of therapeutic effect of Longchai Formula Granule on chronic hepatitis B patients: A double-blind, controlled and randomized clinical trial. BIO Web of Conferences 2017; 8 doi: 10.1051/bioconf/20170801029
|
| 3 |
F. Bohne, U. Protzer. Adoptive T‐cell therapy as a therapeutic option for chronic hepatitis B. Journal of Viral Hepatitis 2007; 14(s1) doi: 10.1111/j.1365-2893.2007.00913.x
|
| 4 |
Ke-lei Su, Fang-shi Zhu. Effect of LongChai decoction-containing serum on the secretion of HBsAg, HBeAg and cell cycle in HepG2.2.15 Cells. 2012 International Symposium on Information Technologies in Medicine and Education 2012; doi: 10.1109/ITiME.2012.6291435
|
| 5 |
Fan Zhang, Gang Wang. A review of non-nucleoside anti-hepatitis B virus agents. European Journal of Medicinal Chemistry 2014; 75 doi: 10.1016/j.ejmech.2014.01.046
|
| 6 |
Yong-Song Guan, Qing He, Ming-Quan Wang, Ping Li. Nuclear factor kappa B and hepatitis viruses. Expert Opinion on Therapeutic Targets 2008; 12(3) doi: 10.1517/14728222.12.3.265
|
| 7 |
Rebecca Pastor, François Habersetzer, Samira Fafi-Kremer, Michel Doffoël, Thomas F Baumert, Jean-Pierre Gut, Françoise Stoll-Keller, Evelyne Schvoerer. Hepatitis B virus mutations potentially conferring adefovir/tenofovir resistance in treatment-naive patients. World Journal of Gastroenterology 2009; 15(6): 753-755 doi: 10.3748/wjg.15.753
|
| 8 |
Altaf Dawood, Syed Abdul Basit, Mahendran Jayaraj, Robert G. Gish. Drugs in Development for Hepatitis B. Drugs 2017; 77(12) doi: 10.1007/s40265-017-0769-2
|
| 9 |
|
| 10 |
Li-Jun Wang, Chang-An Geng, Yun-Bao Ma, Jie Luo, Xiao-Yan Huang, Hao Chen, Ning-Jia Zhou, Xue-Mei Zhang, Ji-Jun Chen. Design, synthesis, and molecular hybrids of caudatin and cinnamic acids as novel anti-hepatitis B virus agents. European Journal of Medicinal Chemistry 2012; 54 doi: 10.1016/j.ejmech.2012.05.012
|
| 11 |
Xiaoyang Bi, Meihong Lin, Yifeng Zhou, Dandan Li, Zuowei Xu, Lijuan Zhou, Jiguang Huang. Insecticidal Activity and Molecular Target by Morphological Analysis, RNAseq, and Molecular Docking of the Aryltetralin Lignan Lactone Helioxanthin, Isolated from Taiwania flousiana Gaussen. Journal of Agricultural and Food Chemistry 2024; 72(10) doi: 10.1021/acs.jafc.3c06384
|
| 12 |
Rui-Hua Guo, Quan Zhang, Yun-Bao Ma, Xiao-Yan Huang, Jie Luo, Li-Jun Wang, Chang-An Geng, Xue-Mei Zhang, Jun Zhou, Zhi-Yong Jiang, Ji-Jun Chen. Synthesis and biological assay of 4-aryl-6-chloro-quinoline derivatives as novel non-nucleoside anti-HBV agents. Bioorganic & Medicinal Chemistry 2011; 19(4) doi: 10.1016/j.bmc.2011.01.006
|
| 13 |
Thu Kim Nguyen, Duyet Van Le. Resistant mutations within the hepatitis B virus reverse transcriptase sequence in treatment failure patients with chronic HBV infection in Vietnam. Journal of Global Antimicrobial Resistance 2023; 33 doi: 10.1016/j.jgar.2023.02.013
|
| 14 |
Steven K. Herrine, Simona Rossi, Victor J. Navarro. Pharmacology and Therapeutics. 2009; doi: 10.1016/B978-1-4160-3291-5.50039-1
|
| 15 |
Sundeep Kumar Goyal, Vinod Kumar Dixit, Suneet Kumar Shukla, Jayant Ghosh, Manas Behera, Manish Tripathi, Neha Gupta, Arttrika Ranjan, Ashok Kumar Jain. Prolonged use of tenofovir and entecavir in hepatitis B virus-related cirrhosis. Indian Journal of Gastroenterology 2015; 34(4) doi: 10.1007/s12664-015-0576-1
|
| 16 |
Guo-Yi Wu, Xiao-Jing Zheng, Chang-Cheng Yin, Dong Jiang, Ling Zhu, Yan Liu, Lai Wei, Yu Wang, Hong-Song Chen. Inhibition of Hepatitis B Virus Replication by Bay 41-4109 and Its Association with Nucleocapsid Disassembly. Journal of Chemotherapy 2008; 20(4) doi: 10.1179/joc.2008.20.4.458
|